,address1,city,zip,country,phone,website,industry,sector,longBusinessSummary,fullTimeEmployees,companyOfficers,auditRisk,boardRisk,compensationRisk,shareHolderRightsRisk,overallRisk,governanceEpochDate,compensationAsOfEpochDate,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,dividendRate,dividendYield,exDividendDate,payoutRatio,beta,trailingPE,forwardPE,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,enterpriseValue,profitMargins,floatShares,sharesOutstanding,heldPercentInsiders,heldPercentInstitutions,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,earningsQuarterlyGrowth,netIncomeToCommon,trailingEps,forwardEps,pegRatio,enterpriseToRevenue,enterpriseToEbitda,exchange,quoteType,symbol,underlyingSymbol,shortName,longName,firstTradeDateEpochUtc,timeZoneFullName,timeZoneShortName,gmtOffSetMilliseconds,currentPrice,targetHighPrice,targetLowPrice,targetMeanPrice,targetMedianPrice,recommendationMean,recommendationKey,numberOfAnalystOpinions,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,totalRevenue,debtToEquity,revenuePerShare,returnOnAssets,returnOnEquity,grossProfits,freeCashflow,operatingCashflow,earningsGrowth,revenueGrowth,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,trailingPegRatio
0,Else-Kroener-Strasse 1,Bad Homburg vor der Höhe,61352,Germany,49 6172 6080,https://www.fresenius.com,Medical Care Facilities,Healthcare,"Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.  This segment provides dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.",315233,"{'maxAge': 1, 'name': 'Mr. Michael  Sen', 'age': 54, 'title': 'CEO, Pres & Chairman of Management Board - Fresenius Management SE', 'yearBorn': 1968, 'fiscalYear': 2022, 'totalPay': 2910000, 'exercisedValue': 0, 'unexercisedValue': 0}",1,3,2,1,2,1693526400,1672444800,86400,2,29.4,29.72,29.5,30.16,29.4,29.72,29.5,30.16,0.92,0.0313,1684368000,0.5169,1.084084,16.758427,9.59164,3537635,3537635,1085915,1159666,1159666,29.91,29.93,16801359872,19.69,30.35,0.40304562,28.3726,26.7514,0.92,0.031292517,EUR,53857366016,0.02404,411106888,563236992,0.26959,0.36525002,35.662,0.8364646,1672444800,1703980800,1688083200,-0.791,1002000000,1.78,3.11,1.61,1.292,11.52,GER,EQUITY,FRE.DE,FRE.DE,FRESENIUS SE&CO KGAA,Fresenius SE & Co. KGaA,910598400,Europe/Berlin,CEST,7200000,29.83,68.0,27.0,36.4,35.0,2.2,buy,19,2471000064,4.387,4674999808,28182999040,0.634,1.202,41685999616,89.669,74.011,0.0242,0.049889997,10725000000,2741499904,4440999936,-0.791,0.034,0.25229,0.11215,0.07084,EUR,1.2751
1,Else-Kroener-Strasse 1,Bad Homburg vor der Höhe,61352,Germany,49 6172 6080,https://www.fresenius.com,Medical Care Facilities,Healthcare,"Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.  This segment provides dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.",315233,"{'maxAge': 1, 'name': 'Ms. Sara Lisa Hennicken', 'age': 42, 'title': 'CFO & Member of the Management Board - Fresenius Management SE', 'yearBorn': 1980, 'fiscalYear': 2022, 'totalPay': 919000, 'exercisedValue': 0, 'unexercisedValue': 0}",1,3,2,1,2,1693526400,1672444800,86400,2,29.4,29.72,29.5,30.16,29.4,29.72,29.5,30.16,0.92,0.0313,1684368000,0.5169,1.084084,16.758427,9.59164,3537635,3537635,1085915,1159666,1159666,29.91,29.93,16801359872,19.69,30.35,0.40304562,28.3726,26.7514,0.92,0.031292517,EUR,53857366016,0.02404,411106888,563236992,0.26959,0.36525002,35.662,0.8364646,1672444800,1703980800,1688083200,-0.791,1002000000,1.78,3.11,1.61,1.292,11.52,GER,EQUITY,FRE.DE,FRE.DE,FRESENIUS SE&CO KGAA,Fresenius SE & Co. KGaA,910598400,Europe/Berlin,CEST,7200000,29.83,68.0,27.0,36.4,35.0,2.2,buy,19,2471000064,4.387,4674999808,28182999040,0.634,1.202,41685999616,89.669,74.011,0.0242,0.049889997,10725000000,2741499904,4440999936,-0.791,0.034,0.25229,0.11215,0.07084,EUR,1.2751
2,Else-Kroener-Strasse 1,Bad Homburg vor der Höhe,61352,Germany,49 6172 6080,https://www.fresenius.com,Medical Care Facilities,Healthcare,"Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.  This segment provides dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.",315233,"{'maxAge': 1, 'name': 'Dr. Sebastian  Biedenkopf', 'age': 58, 'title': 'Chief Legal Officer, HR, Labor Relations Director, Risk Mgmt & Member of Mgmt. Board', 'yearBorn': 1964, 'fiscalYear': 2022, 'totalPay': 1515000, 'exercisedValue': 0, 'unexercisedValue': 0}",1,3,2,1,2,1693526400,1672444800,86400,2,29.4,29.72,29.5,30.16,29.4,29.72,29.5,30.16,0.92,0.0313,1684368000,0.5169,1.084084,16.758427,9.59164,3537635,3537635,1085915,1159666,1159666,29.91,29.93,16801359872,19.69,30.35,0.40304562,28.3726,26.7514,0.92,0.031292517,EUR,53857366016,0.02404,411106888,563236992,0.26959,0.36525002,35.662,0.8364646,1672444800,1703980800,1688083200,-0.791,1002000000,1.78,3.11,1.61,1.292,11.52,GER,EQUITY,FRE.DE,FRE.DE,FRESENIUS SE&CO KGAA,Fresenius SE & Co. KGaA,910598400,Europe/Berlin,CEST,7200000,29.83,68.0,27.0,36.4,35.0,2.2,buy,19,2471000064,4.387,4674999808,28182999040,0.634,1.202,41685999616,89.669,74.011,0.0242,0.049889997,10725000000,2741499904,4440999936,-0.791,0.034,0.25229,0.11215,0.07084,EUR,1.2751
3,Else-Kroener-Strasse 1,Bad Homburg vor der Höhe,61352,Germany,49 6172 6080,https://www.fresenius.com,Medical Care Facilities,Healthcare,"Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.  This segment provides dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.",315233,"{'maxAge': 1, 'name': 'Ms. Helen  Giza', 'age': 54, 'title': 'Member of the Management Board - Fresenius Management SE', 'yearBorn': 1968, 'fiscalYear': 2022, 'totalPay': 1983876, 'exercisedValue': 0, 'unexercisedValue': 0}",1,3,2,1,2,1693526400,1672444800,86400,2,29.4,29.72,29.5,30.16,29.4,29.72,29.5,30.16,0.92,0.0313,1684368000,0.5169,1.084084,16.758427,9.59164,3537635,3537635,1085915,1159666,1159666,29.91,29.93,16801359872,19.69,30.35,0.40304562,28.3726,26.7514,0.92,0.031292517,EUR,53857366016,0.02404,411106888,563236992,0.26959,0.36525002,35.662,0.8364646,1672444800,1703980800,1688083200,-0.791,1002000000,1.78,3.11,1.61,1.292,11.52,GER,EQUITY,FRE.DE,FRE.DE,FRESENIUS SE&CO KGAA,Fresenius SE & Co. KGaA,910598400,Europe/Berlin,CEST,7200000,29.83,68.0,27.0,36.4,35.0,2.2,buy,19,2471000064,4.387,4674999808,28182999040,0.634,1.202,41685999616,89.669,74.011,0.0242,0.049889997,10725000000,2741499904,4440999936,-0.791,0.034,0.25229,0.11215,0.07084,EUR,1.2751
4,Else-Kroener-Strasse 1,Bad Homburg vor der Höhe,61352,Germany,49 6172 6080,https://www.fresenius.com,Medical Care Facilities,Healthcare,"Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.  This segment provides dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.",315233,"{'maxAge': 1, 'name': 'Mr. Pierluigi  Antonelli', 'title': 'Member of Management Board of Fresenius Management SE & CEO of Fresenius Kabi', 'exercisedValue': 0, 'unexercisedValue': 0}",1,3,2,1,2,1693526400,1672444800,86400,2,29.4,29.72,29.5,30.16,29.4,29.72,29.5,30.16,0.92,0.0313,1684368000,0.5169,1.084084,16.758427,9.59164,3537635,3537635,1085915,1159666,1159666,29.91,29.93,16801359872,19.69,30.35,0.40304562,28.3726,26.7514,0.92,0.031292517,EUR,53857366016,0.02404,411106888,563236992,0.26959,0.36525002,35.662,0.8364646,1672444800,1703980800,1688083200,-0.791,1002000000,1.78,3.11,1.61,1.292,11.52,GER,EQUITY,FRE.DE,FRE.DE,FRESENIUS SE&CO KGAA,Fresenius SE & Co. KGaA,910598400,Europe/Berlin,CEST,7200000,29.83,68.0,27.0,36.4,35.0,2.2,buy,19,2471000064,4.387,4674999808,28182999040,0.634,1.202,41685999616,89.669,74.011,0.0242,0.049889997,10725000000,2741499904,4440999936,-0.791,0.034,0.25229,0.11215,0.07084,EUR,1.2751
5,Else-Kroener-Strasse 1,Bad Homburg vor der Höhe,61352,Germany,49 6172 6080,https://www.fresenius.com,Medical Care Facilities,Healthcare,"Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.  This segment provides dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.",315233,"{'maxAge': 1, 'name': 'Dr. Michael Sven Moser Ph.D.', 'age': 45, 'title': 'Member of Management Board of Fresenius Management SE', 'yearBorn': 1977, 'exercisedValue': 0, 'unexercisedValue': 0}",1,3,2,1,2,1693526400,1672444800,86400,2,29.4,29.72,29.5,30.16,29.4,29.72,29.5,30.16,0.92,0.0313,1684368000,0.5169,1.084084,16.758427,9.59164,3537635,3537635,1085915,1159666,1159666,29.91,29.93,16801359872,19.69,30.35,0.40304562,28.3726,26.7514,0.92,0.031292517,EUR,53857366016,0.02404,411106888,563236992,0.26959,0.36525002,35.662,0.8364646,1672444800,1703980800,1688083200,-0.791,1002000000,1.78,3.11,1.61,1.292,11.52,GER,EQUITY,FRE.DE,FRE.DE,FRESENIUS SE&CO KGAA,Fresenius SE & Co. KGaA,910598400,Europe/Berlin,CEST,7200000,29.83,68.0,27.0,36.4,35.0,2.2,buy,19,2471000064,4.387,4674999808,28182999040,0.634,1.202,41685999616,89.669,74.011,0.0242,0.049889997,10725000000,2741499904,4440999936,-0.791,0.034,0.25229,0.11215,0.07084,EUR,1.2751
6,Else-Kroener-Strasse 1,Bad Homburg vor der Höhe,61352,Germany,49 6172 6080,https://www.fresenius.com,Medical Care Facilities,Healthcare,"Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.  This segment provides dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.",315233,"{'maxAge': 1, 'name': 'Mr. Markus  Georgi', 'title': 'Sr. VP of Investor Relations', 'exercisedValue': 0, 'unexercisedValue': 0}",1,3,2,1,2,1693526400,1672444800,86400,2,29.4,29.72,29.5,30.16,29.4,29.72,29.5,30.16,0.92,0.0313,1684368000,0.5169,1.084084,16.758427,9.59164,3537635,3537635,1085915,1159666,1159666,29.91,29.93,16801359872,19.69,30.35,0.40304562,28.3726,26.7514,0.92,0.031292517,EUR,53857366016,0.02404,411106888,563236992,0.26959,0.36525002,35.662,0.8364646,1672444800,1703980800,1688083200,-0.791,1002000000,1.78,3.11,1.61,1.292,11.52,GER,EQUITY,FRE.DE,FRE.DE,FRESENIUS SE&CO KGAA,Fresenius SE & Co. KGaA,910598400,Europe/Berlin,CEST,7200000,29.83,68.0,27.0,36.4,35.0,2.2,buy,19,2471000064,4.387,4674999808,28182999040,0.634,1.202,41685999616,89.669,74.011,0.0242,0.049889997,10725000000,2741499904,4440999936,-0.791,0.034,0.25229,0.11215,0.07084,EUR,1.2751
7,Else-Kroener-Strasse 1,Bad Homburg vor der Höhe,61352,Germany,49 6172 6080,https://www.fresenius.com,Medical Care Facilities,Healthcare,"Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.  This segment provides dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.",315233,"{'maxAge': 1, 'name': 'Matthias  Link', 'title': 'Sr. VP Corp. Communications', 'exercisedValue': 0, 'unexercisedValue': 0}",1,3,2,1,2,1693526400,1672444800,86400,2,29.4,29.72,29.5,30.16,29.4,29.72,29.5,30.16,0.92,0.0313,1684368000,0.5169,1.084084,16.758427,9.59164,3537635,3537635,1085915,1159666,1159666,29.91,29.93,16801359872,19.69,30.35,0.40304562,28.3726,26.7514,0.92,0.031292517,EUR,53857366016,0.02404,411106888,563236992,0.26959,0.36525002,35.662,0.8364646,1672444800,1703980800,1688083200,-0.791,1002000000,1.78,3.11,1.61,1.292,11.52,GER,EQUITY,FRE.DE,FRE.DE,FRESENIUS SE&CO KGAA,Fresenius SE & Co. KGaA,910598400,Europe/Berlin,CEST,7200000,29.83,68.0,27.0,36.4,35.0,2.2,buy,19,2471000064,4.387,4674999808,28182999040,0.634,1.202,41685999616,89.669,74.011,0.0242,0.049889997,10725000000,2741499904,4440999936,-0.791,0.034,0.25229,0.11215,0.07084,EUR,1.2751
